Chacon R - Search Results

1

Less efficacy with alternating regimen as adjuvant chemotherapy in stage II node-positive breast cancer: results at 8 years (Pronacam 85).

Chacon R, Romero Acuña L, Blajman C, Galvez C, Bruno M, Romero A, Chiessa G, Bader M, Schwan R, Albera C, Santarelli MT, Sousa Martínez F, Nadal J, Viniegra M. Chacon R, et al. Br J Cancer. 1997;76(4):545-50. doi: 10.1038/bjc.1997.423. Br J Cancer. 1997. PMID: 9275035 Free PMC article. Clinical Trial.

2

A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.

Blajman C, Balbiani L, Block J, Coppola F, Chacon R, Fein L, Bonicatto S, Alvarez A, Schmilovich A, Delgado FM. Blajman C, et al. Among authors: chacon r. Cancer. 1999 Mar 1;85(5):1091-7. Cancer. 1999. PMID: 10091793 Clinical Trial.

3

Axillary recurrence after sentinel node biopsy for operable breast cancer.

Loza J, Colo F, Nadal J, Viniegra M, Chacón R. Loza J, et al. Among authors: chacon r. Eur J Surg Oncol. 2002 Dec;28(8):897-8. doi: 10.1053/ejso.2002.1376. Eur J Surg Oncol. 2002. PMID: 12481793 No abstract available.

4

Relation between delay and survival in 596 patients with breast cancer.

Machiavelli M, Leone B, Romero A, Perez J, Vallejo C, Bianco A, Rodriguez R, Estevez R, Chacon R, Dansky C, et al. Machiavelli M, et al. Among authors: chacon r. Oncology. 1989;46(2):78-82. doi: 10.1159/000226689. Oncology. 1989. PMID: 2710480

5

Phase II trial of 4'-epi-doxorubicin in locally advanced or metastatic gastric cancer.

Cazap E, Estevez R, Bruno M, Levy D, Algamiz C, Chacon R, Badano C, Romero A, Desimone G, Roca E, et al. Cazap E, et al. Among authors: chacon r. Tumori. 1988 Jun 30;74(3):313-5. doi: 10.1177/030089168807400312. Tumori. 1988. PMID: 3165228

6

Impact of delay to treatment upon survival in 1067 patients with breast-cancer.

Rabinovich M, Vallejo C, Perez J, Rodriguez R, Cuevas M, Machiavelli M, Lacava J, Leone B, Romero A, Mickiewicz E, Chacon R, Estevez R. Rabinovich M, et al. Among authors: chacon r. Int J Oncol. 1993 Feb;2(2):197-201. Int J Oncol. 1993. PMID: 21573536

7

Influence of apoptosis and cell cycle regulator proteins on chemotherapy response and survival in stage IIIA/IIIB NSCLC patients.

Morero JL, Poleri C, Martín C, Van Kooten M, Chacón R, Rosenberg M. Morero JL, et al. Among authors: chacon r. J Thorac Oncol. 2007 Apr;2(4):293-8. doi: 10.1097/01.JTO.0000263711.54073.fa. J Thorac Oncol. 2007. PMID: 17409800 Free article.

8

[Treatment with large doses of Endoxan].

Araujo E, Estevez R, Sanchez Suarez R, Chacon R, Gonzalez G. Araujo E, et al. Among authors: chacon r. Med Monatsschr. 1967 Aug;21(8):371-3. Med Monatsschr. 1967. PMID: 5597100 German. No abstract available.

9

[Emesis due to cytostatic drugs. Update and review of our experiences].

Chacón RD, Bruera ED, Roca E. Chacón RD, et al. Medicina (B Aires). 1983;43(6 Pt 1):713-20. Medicina (B Aires). 1983. PMID: 6679037 Spanish. No abstract available.

10

Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study.

Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Bruera E, et al. Among authors: chacon r. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):751-4. Cancer Treat Rep. 1985. PMID: 2410117 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters